Sobre la empresa

We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.

Bristol Myers Squibb has been in Ireland for over 50 years, and today we offer career opportunities across multiple functions, including Biologics Manufacturing, External Manufacturing and Commercial.

BMS first began operations in Ireland in 1964 with an Active Pharmaceutical Ingredient Plant (API) in Swords, County Dublin. The current BMS operations in Ireland include a newly constructed state-of-the-art biologics drug-substance manufacturing facility in Cruiserath, Dublin 15 and External Manufacturing divisions in Blanchardstown, Dublin 15 and Shannon, Co. Clare. BMS Ireland employs approximately 650 people.

Dirección

External Manufacturing:
Bristol Myers Squibb Pharmaceuticals uc
Plaza 254 - Blanchardstown Corporate Park 2
Dublin 15 - D15 T867
Ireland
Cruiserath Biologics:
Bristol Myers Squibb,
Cruiserath Road
Mulhuddart
Dublin 15
Ireland

Datos de contacto

Teléfono de información médica
1 800 749 749

Sitio web de información médica
Bristol Myers Squibb Medical Information Online for Ireland

Correo electrónico de Información Médica
medical.information@bms.com

Efectos secundarios y reclamaciones de producto

To report an Adverse Event please contact us at:

Comunicar un efecto adverso por teléfono
1 800 749 749

Comunicar un efecto adverso por correo electrónico
medical.information@bms.com

Website
https://www.bms.com/ie

BMS productos

Los medicamentos marcados con unestán sujetos a un seguimiento adicional que permite la rápida identificación de nueva información de seguridad. Usted puede contribuir comunicando cualquier efecto secundario que conozca.

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z

Abraxane®
(nab-paclitaxel)

Adcortyl®
(triamcinolone acetonide)

Azactam®
(aztreonam)

Baraclude®
(entecavir)

Eliquis® (Co-Promoted Pfizer)
(apixaban)

Imnovid®
(pomalidomide)

Opdivo®
(nivolumab)

Opdivo® + Yervoy® Regimen
(nivolumab, ipilimumab)

Orencia®
(abatacept)

Revlimid®
(lenalidomide)

Sprycel®
(dasatinib)

Thalidomide BMS
(thalidomide)

Vidaza®
(azacitidine)

Zeposia®
(ozanimod)

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z
Ultima actualización: 19/04/2024